Results from British Columbia’s Community Drug Checking Service January 2020 – October 2020
Bibliography: Interventions – Harm Reduction
Assessment of the harms of gamma-hydroxybutyric acid, gamma-butyrolactone, and closely related compounds
This report provides an updated harms assessment of gamma-hydroxybutyric acid (GHB) and related substances (ACMD)
Supervised Injection Facilities and Other Supervised Consumption Sites: Effectiveness and Value
The purpose of this assessment is to evaluate the health and economic outcomes of a Supervised Injection Facility. This review seeks to answer the question: What is the net health benefit of implementing a SIF (which includes an SSP) versus an SSP alone? (ICER)
Key findings from the ‘Australians’ Drug Use: Adapting to Pandemic Threats’ (ADAPT) Study Wave 2
The Australians’ Drug Use: Adapting to Pandemic Threats (ADAPT) Study is exploring the short and long-term impact of the COVID-19 pandemic on the experiences of Australians who use illicit drugs (NDARC)
Preliminary patterns in circumstances surrounding opioid-related deaths in Ontario during the COVID-19 pandemic
This report describes the preliminary patterns in circumstances surrounding opioid-related deaths in Ontario during COVID-19. An understanding of these circumstances is urgently needed to inform interventions and policies to prevent further opioid-related mortality in the midst of this pandemic (The Ontario drug policy research network)
Prevention and Treatment of HIV Among People Living with Substance Use and/or Mental Disorders
This guide reviews effective programs and practices to prevent HIV and increase adherence to and retention in care (SAMHSA)
The Global State of Harm Reduction 2020
The Global State of Harm Reduction is the only report that provides an independent analysis of harm reduction in the world (Harm Reduction International)
How to use the ASSIST-Lite screening tool to identify alcohol and drug use and tobacco smoking
Health and social care professionals are well placed to provide interventions targeted at all substances. This tool will help you to identify risky drug and alcohol use and tobacco smoking, and respond in an evidence-based way. This will contribute to reducing premature mortality and morbidity (PHE)
Characteristics of people who used the Melbourne and Sydney medically supervised injecting facilities surveyed in the Illicit Drug Reporting System 2019
In this bulletin, we summarise findings from the Sydney and Melbourne survey samples who report use of the supervised injecting facilities in their city (NDARC)
Expanded Access to Naloxone Can Curb Opioid Overdose Deaths
Changes to prescribing laws to improve availability of the overdose reversal drug can reduce fatalities (PEW)
The impact of arrest and seizure on drug crime and harms: A systematic review
Drawing on the Global Policing Database (GPD), this review assesses the impact of supplier arrests and seizures on drug crime, drug use, drug price, drug purity, and drug harm outcomes (Australian Crime Commission)
EMCDDA releases study findings on the impact of COVID-19 on drug markets, use and services in the eastern ENP region
The expansion of contactless drug dealing, the increase in the use of licit drugs and the adaptation of drug treatment protocols during lockdown are among the findings highlighted today in a new EMCDDA report: Impact of COVID-19 on drug markets, drug use, drug-related harms and responses in east European Neighbourhood Policy countries
COVID-19: guidance for commissioners and providers of services for people who use drugs or alcohol
This guidance outlines COVID-19 advice for commissioners and service providers involved in assisting people who are dependent on drugs or alcohol or both (Public Health England)
Preventable injecting-related injuries and diseases reported by many people who inject drugs
In a new report by researchers at the National Drug and Alcohol Research Centre (NDARC), UNSW Sydney, data from 897 face-to-face interviews with PWID from the 2019 Illicit Drug Reporting System (IDRS) were analysed
Recreational cannabis regulation and harm reduction
BERL advice to the Ministry of Justice (New Zealand)
Support and informational needs of ‘at-risk’ groups highlighted in new SDF report
A new report that identifies specific risks and informational needs of certain ‘at-risk’ groups in Scotland has been published today by Scottish Drugs Forum
Does it matter where you get medication for opioid use disorder? A comparison of three types of clinics
Do substance-related outcomes vary across different types of community clinics? (Recovery Research Institute)
Substance use disorder recovery – there’s an app for that… but who uses it and who benefits?
To begin to address this gap in the clinical literature, the authors conducted an analysis of Sober Grid, a popular substance use disorder (SUD) recovery smartphone application (Recovery Research Institute)
Managing drug and alcohol misuse at work
Our report, written with input from charities and experts in the space, examines the management and prevention of drug and alcohol misuse at work (CIPD)
Overdose Education and Naloxone Distribution Within Syringe Service Programs — United States, 2019
In 2019, among 263 SSPs responding to an online survey, 247 (94%) had implemented OEND. The number of persons who received naloxone per opioid overdose death and the number of naloxone doses distributed per opioid overdose death during the previous year varied by census division (CDC)
- 1
- 2
- 3
- …
- 18
- Next Page »
